{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:56:56Z","timestamp":1791399416427,"version":"4.3.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.7759\/cureus.113931","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:56:08Z","timestamp":1785840968000},"source":"Crossref","is-referenced-by-count":1,"title":["Fibromyalgia and Central Sensitization in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hassan A","family":"Eltoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namaa Tilal Osman","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagangal Abdelhadi","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania Gamal","family":"Hassanelbasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec L","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJ, et al.. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024, 83:706-19. 10.1136\/ard-2024-225531","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro S","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, et al.. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023, 82:19-34. 10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen JS","year":"2018","unstructured":"Smolen JS, Sch\u00f6ls M, Braun J, et al.. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018, 77:3-17. 10.1136\/annrheumdis-2017-211734","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe F","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al.. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016, 46:319-29. 10.1016\/j.semarthrit.2016.08.012","journal-title":"Semin Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf CJ","year":"2011","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011, 152:S2-S15. 10.1016\/j.pain.2010.09.030","journal-title":"Pain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles M","year":"2021","unstructured":"Fitzcharles M, Cohen S, Clauw D, et al.. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021, 397:2098-110. 10.1016\/S0140-6736(21)00392-5","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.06.005","article-title":"The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis","volume":"33","author":"Zhao SS","year":"2019","unstructured":"Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019, 33:101423. 10.1016\/j.berh.2019.06.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-01","article-title":"JBI Manual for Evidence Synthesis","author":"Aromataris E","year":"2024","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI Manual for Evidence Synthesis. JBI, 2024. 10.46658\/JBIMES-24-01"},{"key":"ref11","unstructured":"The Newcastle-Ottawa Scale for assessing the quality of nonrandomised studies in meta-analyses. (2026). Accessed. June 1, 2026: https:\/\/www.ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0525-5","article-title":"A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis","volume":"17","author":"Joharatnam N","year":"2015","unstructured":"Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015, 17:11. 10.1186\/s13075-015-0525-5","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151491","article-title":"The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study","volume":"43","author":"Brikman S","year":"2016","unstructured":"Brikman S, Furer V, Wollman J, et al.. The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol. 2016, 43:1749-54. 10.3899\/jrheum.151491","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0177","article-title":"Central sensitization in psoriatic arthritis: relationship with composite measures of disease activity, functional disability, and health-related quality of life","volume":"51","author":"Salaffi F","year":"2024","unstructured":"Salaffi F, Farah S, Bianchi B, Di Carlo M. Central sensitization in psoriatic arthritis: relationship with composite measures of disease activity, functional disability, and health-related quality of life. J Rheumatol. 2024, 51:144-9. 10.3899\/jrheum.2023-0177","journal-title":"J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61020319","article-title":"Central sensitization and its role in persistent pain among spondyloarthritis patients on biological treatments","volume":"61","author":"\u00d6z N","year":"2025","unstructured":"\u00d6z N, \u00d6zer A, Duru\u00f6z MT. Central sensitization and its role in persistent pain among spondyloarthritis patients on biological treatments. Medicina (Kaunas). 2025, 61:10.3390\/medicina61020319","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key206","article-title":"Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register","volume":"57","author":"Macfarlane GJ","year":"2018","unstructured":"Macfarlane GJ, MacDonald RI, Pathan E, et al.. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatology (Oxford). 2018, 57:1982-90. 10.1093\/rheumatology\/key206","journal-title":"Rheumatology (Oxford)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2023.0009","article-title":"The effect of central sensitization on disease activity measures, quality of life and clinical parameters in axial spondyloarthritis: a cross-sectional study","volume":"30","author":"\u015ea\u015f S","year":"2023","unstructured":"\u015ea\u015f S, Cengiz G, Kaplan H. The effect of central sensitization on disease activity measures, quality of life and clinical parameters in axial spondyloarthritis: a cross-sectional study. J Rheum Dis. 2023, 30:176-84. 10.4078\/jrd.2023.0009","journal-title":"J Rheum Dis"},{"key":"ref19","article-title":"Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia","volume":"31","author":"Wolfe F","year":"2004","unstructured":"Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. J Rheumatol. 2004, 31:695-700.","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-024-01505-4","article-title":"Assessing the effects of distinct biologic therapies on rheumatoid arthritis pain by nociceptive, neuropathic and nociplastic pain components: a randomised feasibility study","volume":"10","author":"Ahmed L","year":"2024","unstructured":"Ahmed L, Biddle K, Blundell A, et al.. Assessing the effects of distinct biologic therapies on rheumatoid arthritis pain by nociceptive, neuropathic and nociplastic pain components: a randomised feasibility study. Pilot Feasibility Stud. 2024, 10:77. 10.1186\/s40814-024-01505-4","journal-title":"Pilot Feasibility Stud"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2025.11011","article-title":"Prevalence of central sensitization and neuropathic pain in patients with psoriatic arthritis: a cross-sectional study","volume":"40","author":"Alp G","year":"2025","unstructured":"Alp G, Kurut Aysin \u0130, Cinakli H, Solmaz D, Akar S. Prevalence of central sensitization and neuropathic pain in patients with psoriatic arthritis: a cross-sectional study. Arch Rheumatol. 2025, 40:87-97. 10.46497\/ArchRheumatol.2025.11011","journal-title":"Arch Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45459","article-title":"Effect of central sensitization in patients with familial Mediterranean fever, axial spondyloarthritis, and both diseases","volume":"15","author":"Kaya MN","year":"2023","unstructured":"Kaya MN, K\u0131l\u0131\u00e7 \u00d6, Do\u011fan A, Y\u0131lmaz S, Tecer D. Effect of central sensitization in patients with familial Mediterranean fever, axial spondyloarthritis, and both diseases. Cureus. 2023, 15:e45459. 10.7759\/cureus.45459","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0943-z","article-title":"Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis","volume":"18","author":"Bello N","year":"2016","unstructured":"Bello N, Etcheto A, B\u00e9al C, Dougados M, Molt\u00f3 A. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther. 2016, 18:42. 10.1186\/s13075-016-0943-z","journal-title":"Arthritis Res Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080366","article-title":"Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management","volume":"36","author":"Coury F","year":"2009","unstructured":"Coury F, Rossat A, Tebib A, Letroublon MC, Gagnard A, Fantino B, Tebib JG. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol. 2009, 36:58-62. 10.3899\/jrheum.080366","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090157","article-title":"Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis","volume":"36","author":"Dhir V","year":"2009","unstructured":"Dhir V, Lawrence A, Aggarwal A, Misra R. Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J Rheumatol. 2009, 36:2443-8. 10.3899\/jrheum.090157","journal-title":"J Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110072","article-title":"Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis","volume":"39","author":"Ton E","year":"2012","unstructured":"Ton E, Bakker MF, Verstappen SM, et al.. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol. 2012, 39:22-7. 10.3899\/jrheum.110072","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2013.03.003","article-title":"The impact of fibromyalgia on disease assessment in rheumatoid arthritis patients","volume":"35","author":"Nawito Z","year":"2013","unstructured":"Nawito Z, Rady HM, Maged LA. The impact of fibromyalgia on disease assessment in rheumatoid arthritis patients. Egypt Rheumatol. 2013, 35:115-9. 10.1016\/j.ejr.2013.03.003","journal-title":"Egypt Rheumatol"},{"key":"ref28","article-title":"Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia","volume":"23","author":"Zammurrad S","year":"2013","unstructured":"Zammurrad S, Munir W, Farooqi A. Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia. J Coll Physicians Surg Pak. 2013, 23:413-7.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118620","article-title":"Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study","volume":"10","author":"da Silva Chakr RM","year":"2015","unstructured":"da Silva Chakr RM, Brenol JC, Behar M, et al.. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study. PLoS One. 2015, 10:e0118620. 10.1371\/journal.pone.0118620","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.11152\/mu.2013.2066.173.ljg","article-title":"The role of ultrasonography in assessing disease activity in patients with rheumatoid arthritis and associated fibromyalgia","volume":"17","author":"Ghib LJ","year":"2015","unstructured":"Ghib LJ, T\u0103ma\u015f MM, Damian LO, Felea I, Muntean LM, Rednic N, Rednic S. The role of ultrasonography in assessing disease activity in patients with rheumatoid arthritis and associated fibromyalgia. Med Ultrason. 2015, 17:339-44. 10.11152\/mu.2013.2066.173.ljg","journal-title":"Med Ultrason"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1258-6","article-title":"Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound","volume":"17","author":"Mian AN","year":"2016","unstructured":"Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, Garrood T. Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord. 2016, 17:404. 10.1186\/s12891-016-1258-6","journal-title":"BMC Musculoskelet Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2017.01.004","article-title":"Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia","volume":"57","author":"Chakr RM","year":"2017","unstructured":"Chakr RM, Brenol C, Ranzolin A, et al.. Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol Engl Ed. 2017, 57:403-11. 10.1016\/j.rbre.2017.01.004","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3792-4","article-title":"The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis","volume":"37","author":"Salaffi F","year":"2017","unstructured":"Salaffi F, Gerardi MC, Atzeni F, et al.. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int. 2017, 37:2035-42. 10.1007\/s00296-017-3792-4","journal-title":"Rheumatol Int"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2021.246","article-title":"Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome","volume":"41","author":"Durmaz Y","year":"2021","unstructured":"Durmaz Y, Ilhanli I. Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome. Ann Saudi Med. 2021, 41:246-52. 10.5144\/0256-4947.2021.246","journal-title":"Ann Saudi Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/msy022","article-title":"Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory","volume":"40","author":"Saitou M","year":"2022","unstructured":"Saitou M, Noda K, Matsushita T, Ukichi T, Kurosaka D. Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory. Clin Exp Rheumatol. 2022, 40:980-7. 10.55563\/clinexprheumatol\/msy022","journal-title":"Clin Exp Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2022.08.002","article-title":"The role of musculoskeletal ultrasound in assessment of disease activity in rheumatoid arthritis patients with fibromyalgia","volume":"45","author":"Sami M","year":"2023","unstructured":"Sami M, Nassr M, El-Ghobashy N, et al.. The role of musculoskeletal ultrasound in assessment of disease activity in rheumatoid arthritis patients with fibromyalgia. Egypt Rheumatol. 2023, 45:7-11. 10.1016\/j.ejr.2022.08.002","journal-title":"Egypt Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64011","article-title":"The prevalence of fibromyalgia in rheumatoid arthritis patients using the Fibromyalgia Assessment Screening Tool (FAST 4) based on the Multidimensional Health Assessment Questionnaire (MDHAQ)","volume":"16","author":"El-Kasmi H","year":"2024","unstructured":"El-Kasmi H, Amine B, Kabbaj A, Rostom S, El Binoune I, El Hilali S, Bahiri R. The prevalence of fibromyalgia in rheumatoid arthritis patients using the Fibromyalgia Assessment Screening Tool (FAST 4) based on the Multidimensional Health Assessment Questionnaire (MDHAQ). Cureus. 2024, 16:e64011. 10.7759\/cureus.64011","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2023.81231","article-title":"Impact of central sensitization on clinical parameters in patients with rheumatoid arthritis","volume":"11","author":"Mesci N","year":"2024","unstructured":"Mesci N, Mesci E, Kandemir EU, Kulcu DG, Celik T. Impact of central sensitization on clinical parameters in patients with rheumatoid arthritis. North Clin Istanb. 2024, 11:140-6. 10.14744\/nci.2023.81231","journal-title":"North Clin Istanb"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/3bs6em","article-title":"Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia","volume":"42","author":"Navarini L","year":"2024","unstructured":"Navarini L, Currado D, Pilato A, et al.. Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia. Clin Exp Rheumatol. 2024, 42:1150-5. 10.55563\/clinexprheumatol\/3bs6em","journal-title":"Clin Exp Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60091449","article-title":"Impact of central sensitization on clinical and functional aspects of psoriatic arthritis","volume":"60","author":"Kaya MN","year":"2024","unstructured":"Kaya MN, Tecer D, K\u0131l\u0131\u00e7 \u00d6, \u00d6zg\u00fcnen MS, Y\u0131lmaz S. Impact of central sensitization on clinical and functional aspects of psoriatic arthritis. Medicina (Kaunas). 2024, 60:10.3390\/medicina60091449","journal-title":"Medicina (Kaunas)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.11.006","article-title":"Central sensitization has major impact on quality of life in patients with axial spondyloarthritis","volume":"52","author":"Kieskamp SC","year":"2022","unstructured":"Kieskamp SC, Paap D, Carbo MJ, et al.. Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. Semin Arthritis Rheum. 2022, 52:151933. 10.1016\/j.semarthrit.2021.11.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200872","article-title":"Chronic pain and assessment of pain sensitivity in patients with axial spondyloarthritis: results from the SPARTAKUS cohort","volume":"48","author":"Mogard E","year":"2021","unstructured":"Mogard E, Olofsson T, Bergman S, et al.. Chronic pain and assessment of pain sensitivity in patients with axial spondyloarthritis: results from the SPARTAKUS cohort. J Rheumatol. 2021, 48:1672-9. 10.3899\/jrheum.200872","journal-title":"J Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-019-0066-7","article-title":"AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)","volume":"3","author":"Macfarlane GJ","year":"2019","unstructured":"Macfarlane GJ, Pathan E, Siebert S, et al.. AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). BMC Rheumatol. 2019, 3:19. 10.1186\/s41927-019-0066-7","journal-title":"BMC Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160104","article-title":"Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice","volume":"43","author":"Wach J","year":"2016","unstructured":"Wach J, Letroublon MC, Coury F, Tebib JG. Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol. 2016, 43:2056-63. 10.3899\/jrheum.160104","journal-title":"J Rheumatol"},{"key":"ref45","article-title":"Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis","volume":"21","author":"Gao R","year":"2021","unstructured":"Gao R. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis. J Musculoskelet Neuronal Interact. 2021, 21:440-6.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa888","article-title":"The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis","volume":"60","author":"Provan SA","year":"2021","unstructured":"Provan SA, Dean LE, Jones GT, Macfarlane GJ. The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis. Rheumatology (Oxford). 2021, 60:4121-9. 10.1093\/rheumatology\/keaa888","journal-title":"Rheumatology (Oxford)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf102","article-title":"Interrelationships of disease activity, central sensitization, psychosocial and lifestyle factors in axial spondyloarthritis","volume":"64","author":"Kieskamp SC","year":"2025","unstructured":"Kieskamp SC, van der Kraan Y, Arends S, et al.. Interrelationships of disease activity, central sensitization, psychosocial and lifestyle factors in axial spondyloarthritis. Rheumatology (Oxford). 2025, 64:3547-55. 10.1093\/rheumatology\/keaf102","journal-title":"Rheumatology (Oxford)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/art.43265","article-title":"Associations between changes in pain sensitization and disease activity following disease-modifying antirheumatic drug therapy in established rheumatoid arthritis","volume":"77","author":"Aydemir B","year":"2025","unstructured":"Aydemir B, Heisler AC, Muhammad LN, et al.. Associations between changes in pain sensitization and disease activity following disease-modifying antirheumatic drug therapy in established rheumatoid arthritis. Arthritis Rheumatol. 2025, 77:1682-8. 10.1002\/art.43265","journal-title":"Arthritis Rheumatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-026-03732-x","article-title":"Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome","volume":"28","author":"Bertsias A","year":"2026","unstructured":"Bertsias A, Flouri I, Emmanouilidou E, et al.. Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome. Arthritis Res Ther. 2026, 28:45. 10.1186\/s13075-026-03732-x","journal-title":"Arthritis Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/jpm16050252","article-title":"Central sensitization in spondyloarthritis: implications for personalized medicine","volume":"16","author":"Carli L","year":"2026","unstructured":"Carli L, Fattorini F, Di Battista M, Esti L, Cigolini C, Mosca M, Delle Sedie A. Central sensitization in spondyloarthritis: implications for personalized medicine. J Pers Med. 2026, 16:10.3390\/jpm16050252","journal-title":"J Pers Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X261453292","article-title":"Central sensitization in psoriatic arthritis: prevalence, clinical correlates, and association with therapeutic refractoriness in an unselected cohort excluding fibromyalgia","volume":"18","author":"Chac\u00f3n C","year":"2026","unstructured":"Chac\u00f3n C, Toledano E, Queir\u00f3 R, et al.. Central sensitization in psoriatic arthritis: prevalence, clinical correlates, and association with therapeutic refractoriness in an unselected cohort excluding fibromyalgia. Ther Adv Musculoskelet Dis. 2026, 18:1759720X261453292. 10.1177\/1759720X261453292","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/art.70202","article-title":"Determinants of difficult-to-manage and treatment-refractory axial spondyloarthritis: a cross-sectional analysis within a longitudinal cohort","author":"Remalante-Rayco P","year":"2026","unstructured":"Remalante-Rayco P, Passalent L, Chim T, et al.. Determinants of difficult-to-manage and treatment-refractory axial spondyloarthritis: a cross-sectional analysis within a longitudinal cohort. Arthritis Rheumatol. 2026, 10.1002\/art.70202","journal-title":"Arthritis Rheumatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15041601","article-title":"The association between neuropathic pain, pain intensity, and inflammatory activity in rheumatoid arthritis","volume":"15","author":"Akar ZA","year":"2026","unstructured":"Akar ZA, Y\u0131ld\u0131r\u0131m D, Karakoyun \u00d6, Kaya K, \u00c7a\u011flayan M, Oktayo\u011flu P, \u00c7evik R. The association between neuropathic pain, pain intensity, and inflammatory activity in rheumatoid arthritis. J Clin Med. 2026, 15:10.3390\/jcm15041601","journal-title":"J Clin Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.5152\/ArchRheumatol.2026.25240","article-title":"Assessment of the concomitance of fibromyalgia in patients with axial spondyloarthritis and rheumatoid arthritis","volume":"41","author":"Caglayan M","year":"2026","unstructured":"Caglayan M, Oktayoglu P, Celik Y, Gunduz \u0130, Sula ZI, Ciftci M, Y\u0131ld\u0131z \u0130. Assessment of the concomitance of fibromyalgia in patients with axial spondyloarthritis and rheumatoid arthritis. Arch Rheumatol. 2026, 41:72-80. 10.5152\/ArchRheumatol.2026.25240","journal-title":"Arch Rheumatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045503","article-title":"Comparison of neuropathic pain symptoms and functionality in hand osteoarthritis and rheumatoid arthritis: a cross-sectional study","volume":"104","author":"\u00c7iftci \u0130nceo\u011flu S","year":"2025","unstructured":"\u00c7iftci \u0130nceo\u011flu S, Ayyildiz A, Kuran B. Comparison of neuropathic pain symptoms and functionality in hand osteoarthritis and rheumatoid arthritis: a cross-sectional study. Medicine (Baltimore). 2025, 104:e45503. 10.1097\/MD.0000000000045503","journal-title":"Medicine (Baltimore)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1801448","article-title":"Prevalence and predictors of kinesiophobia in psoriatic arthritis: the role of central sensitization and comorbidities","volume":"13","author":"Llamas-Ramos R","year":"2026","unstructured":"Llamas-Ramos R, Llamas-Ramos I, Alvarado-Omenat JJ, et al.. Prevalence and predictors of kinesiophobia in psoriatic arthritis: the role of central sensitization and comorbidities. Front Med (Lausanne). 2026, 13:1801448. 10.3389\/fmed.2026.1801448","journal-title":"Front Med (Lausanne)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ero.2025.07.001","article-title":"Altered somatosensory profiles in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic sclerosis","volume":"1","author":"Petzinna SM","year":"2025","unstructured":"Petzinna SM, Bauer CJ, Schrapper RS, et al.. Altered somatosensory profiles in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic sclerosis. EULAR Rheumatol Open. 2025, 1:165-72. 10.1016\/j.ero.2025.07.001","journal-title":"EULAR Rheumatol Open"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-025-00487-y","article-title":"Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital","volume":"65","author":"Pontes de Oliveira MN","year":"2025","unstructured":"Pontes de Oliveira MN, de Jesus Sena D, de Melo AK, Egypto DC, Botelho LF, de Sousa Braz A. Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital. Adv Rheumatol. 2025, 65:52. 10.1186\/s42358-025-00487-y","journal-title":"Adv Rheumatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03725-2","article-title":"Sex differences in pain-related biopsychosocial assessments in patients with axial spondyloarthritis","volume":"28","author":"van der Kraan YM","year":"2026","unstructured":"van der Kraan YM, Paap D, Timmerman H, Wink F, Arends S, Reneman M, Spoorenberg A. Sex differences in pain-related biopsychosocial assessments in patients with axial spondyloarthritis. Arthritis Res Ther. 2026, 28:27. 10.1186\/s13075-025-03725-2","journal-title":"Arthritis Res Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy G","year":"2022","unstructured":"Nagy G, Roodenrijs NM, Welsing PM, et al.. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2022, 81:20-33. 10.1136\/annrheumdis-2021-220973","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/503793-fibromyalgia-and-central-sensitization-in-rheumatoid-arthritis-psoriatic-arthritis-and-spondyloarthritis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:56:16Z","timestamp":1785840976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/503793-fibromyalgia-and-central-sensitization-in-rheumatoid-arthritis-psoriatic-arthritis-and-spondyloarthritis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.113931","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}